Buy KLOW Peptide Blend in Australia
Buy KLOW in Australia from Macropus Peptides as an 80mg research vial that brings four compounds together: GHK-Cu, BPC-157, TB-500 and KPV. It is the GLOW trio with the anti-inflammatory tripeptide KPV added, so one reconstitution covers copper transport, growth factor signalling, actin binding and inflammatory signalling models at once. The four peptides are freeze-dried as a single cake in a sealed vial, labelled with blend name, total strength, batch code and storage temperature, and the certificate for each lot lists the measured amount of every component. KLOW is priced and ready to order, and it costs far less than the four matching single vials bought separately. Each component is still sold alone for control arms. Add bacteriostatic water to the order and KLOW is posted from Australian stock to any Australian address. Supplied to adults for in-vitro laboratory research only, not for use in people or animals.
| Compound | KLOW |
|---|---|
| Amount | 80 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
| Testing | HPLC purity and mass spectrometry identity, every batch |
| Certificate of analysis | Available for every lot, matched to the lot number on the label |
KLOW 80mg vial
Enter the diluent volume added to this vial to see the solution concentration. Laboratory calculation only, not dosing guidance.
Buy KLOW Peptide Australia: 80mg Blend Vial
Macropus Peptides sells KLOW as a single 80mg vial of four research peptides dried together, priced and ready to order. It is the broadest blend in our recovery research range, and one vial gives a laboratory one reconstitution and one batch record for all four compounds.
KLOW peptide Australia: what the 80mg blend contains
The blend is GLOW with one addition. Inside are GHK-Cu, the copper-bound tripeptide; BPC-157, fifteen residues from a stomach protein; TB-500, synthetic material based on thymosin beta 4; and KPV, the final three residues of alpha-melanocyte stimulating hormone. The customary split for an 80mg four-way blend is 50mg of the copper peptide plus 10mg of each remaining peptide. Still, the lot certificate has the final word, and its measured values are the ones to calculate from.
Why KPV is added to the GLOW trio in KLOW
The first three peptides are studied mainly for what cells build and how they move. KPV brings a fourth line of study, inflammatory signalling inside the cell, measured in intestinal and immune cell models. Adding it lets a laboratory look at repair-related and inflammation-related pathways in one preparation. The trade-off is the same as for any blend: the ratio is fixed, and a result from the mixture cannot be traced to one component without single-compound controls.
KLOW blend: how the four peptides work in research
The copper tripeptide ferries copper into cells, and in fibroblast work its complex was tracked for effects on collagen. BPC-157 has been tied to focal adhesion kinase activity in tendon cells and to VEGFR2 in vessel models. Thymosin beta 4 keeps a reserve of unpolymerised actin, which steers cell shape and movement. KPV, the smallest of the four, rides into gut and immune cells on the PepT1 peptide carrier, and researchers have tracked what it does to NF-kB and MAP kinase activity there. Each works independently; none has been shown to change the others.
KLOW research: what the studies show
Nobody has yet published on the four-part blend itself. The record belongs to the components. For KPV, a 2008 Gastroenterology report measured carrier-mediated uptake in intestinal cells and mouse colitis models. The copper tripeptide literature includes a 1988 FEBS Letters report from fibroblast culture, BPC-157 has a 2011 tendon fibroblast report in the Journal of Applied Physiology, and a 2005 Trends in Molecular Medicine review covers thymosin beta 4. Reviews of freeze-dried protein products, such as a 2000 paper in the International Journal of Pharmaceutics, explain why several peptides can share one dry cake. Our KLOW research studies library lists the formulation papers.
KLOW vs GLOW and single vials: which to buy
Against the singles, the blend saves a great deal. Bought separately, a 50mg GHK-Cu vial and 10mg vials of BPC-157, TB-500 and KPV cost roughly three times the price of one blended vial. Singles remain the right choice when a design needs any compound alone or a different ratio. Against GLOW, the difference is only the KPV share, so pairing the two blends in one experiment isolates what KPV contributes.
KLOW 80mg vial specifications
| Specification | Detail |
|---|---|
| Compound | KLOW |
| Amount | 80 mg |
| Form | Lyophilised powder |
| Category | Recovery research |
| Storage | -20 °C, protect from light |
All four peptides form one pale blue freeze-dried cake under a crimped cap. The label names the blend, the total strength, the batch code and the storage temperature. Quote the batch code to receive the certificate, where every component is reported separately.
KLOW price in Australia
| Strength | Price | Price per mg |
|---|---|---|
| KLOW 80mg | $149.99 | $1.87 per mg |
This four-peptide vial is sold at a fixed figure in Australian dollars, with no quote needed. Measured on total peptide it is the cheapest blend per milligram we sell, though the value only holds if a fixed four-way ratio suits your study.
KLOW 80mg: where to buy in Australia
There is one size of this blend. It suits laboratories that already handle several of these compounds and want a long combined series on one batch. Eight millilitres of diluent turns the cake into a 10 mg per mL solution counting all four peptides.
Best place to buy KLOW peptide Australia
- Four peptides, one priced vial
- Components itemised on each certificate
- All four also sold singly
- GLOW stocked as a comparison
- Sent from our Australian shelves, never via customs
KLOW how to get: buy the blend online
- Put the 80mg vial in your cart
- Add singles if running controls
- Include a 10 mL diluent bottle
- Confirm adult research use and pay
- Request the batch certificate
KLOW calculator: water volumes for the 80mg blend
Type any diluent volume into the KLOW calculator to read total peptide per mL. Eight millilitres sets the blend at 10 mg per mL and four sets it at 20. Split by component at 8 mL, a 50mg copper share gives 6.25 mg per mL while every 10mg share gives 1.25, so confirm the certificate values first. The 3 mL bottle packed in the KLOW starter kit takes the vial to about 26.7 mg per mL.
Is KLOW available in Australia
Yes, strictly as bench research material. Not one of its four peptides holds ARTG registration or TGA approval, so the blend is barred from human or veterinary supply. The Poisons Standard lists every component separately, and each listing deserves a check before a lab orders.
KLOW for sale Australia wide
Parcels reach every state and territory, from Newcastle and Wollongong to Perth and Cairns. The recovery research range lists each component on its own, and lab supplies and kits carries diluents and consumables.
References
- PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008.
- Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988.
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology. 2011.
- Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends in Molecular Medicine. 2005.
- Lyophilization and development of solid protein pharmaceuticals. International Journal of Pharmaceutics. 2000.
Scientific content compiled from the peer-reviewed literature above by the Macropus Peptides technical team. Information is provided for research reference only.